We have been funded with a project of the call for the Valorisation Fund (FVal) of the Fund for the Promotion of Innovation (F2I) from La Fundació Bosch i Gimpera. These grants are supported by the Secretary of Universities and Research of the Department of Business and Knowledge of the Generalitat de Catalunya and are co-financed with the European Regional Development Fund (FEDER).
With this grant we can continue working, in collaboration with Vall d’Hebron Institute of Oncology (VHIO), to  develop a new technology based in the generation of PROTAC molecules to improve and optimize the already existing immunotherapy based on the CAR-T cell generation.

This has been published in the news section of la Fundació Bosch i Gimpera and the full text can be found here: http://www.fbg.ub.edu/actualitat/nova-estrategia-millorar-produccio-leficacia-dun-tipus-dimmunoterapia-contra-cancer/